Hepatology International

, Volume 5, Issue 1, pp 597–602

Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still’s disease

  • Sanjaya K. Satapathy
  • M. Isabel Fiel
  • Juan Del Rio Martin
  • Costica Aloman
  • Thomas D. Schiano
Case Report

DOI: 10.1007/s12072-010-9218-y

Cite this article as:
Satapathy, S.K., Isabel Fiel, M., Del Rio Martin, J. et al. Hepatol Int (2011) 5: 597. doi:10.1007/s12072-010-9218-y

Abstract

Hemophagocytic syndrome is a potentially fatal complication that rarely occurs after liver transplantation. We present a 25-year-old man with a history of Still’s disease who presented with fever, arthralgia, and elevated serum ferritin levels 6 months after undergoing liver transplantation for fulminant hepatic failure due to autoimmune hepatitis potentially triggered by infliximab therapy. Liver biopsy demonstrated features consistent with hemophagocytic syndrome. The patient was successfully treated with a course of high dose steroids and had complete resolution of his symptoms and normalization of liver chemistry test abnormalities. Patients with Still’s disease may rarely complicate with fulminant hepatic failure with infliximab therapy. Hemophagocytic syndrome a rare potentially life threatening condition may occur in such patients following liver transplantation.

Keywords

Rheumatoid arthritis Macrophage activation syndrome Liver transplantation 

Copyright information

© Asian Pacific Association for the Study of the Liver 2010

Authors and Affiliations

  • Sanjaya K. Satapathy
    • 1
  • M. Isabel Fiel
    • 1
  • Juan Del Rio Martin
    • 1
  • Costica Aloman
    • 1
  • Thomas D. Schiano
    • 1
  1. 1.Division of Liver DiseasesMount Sinai School of MedicineNew YorkUSA

Personalised recommendations